newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound

Allowed Claims Cover Supera-CBD™ as a New Molecular Entity and Pharmaceutical Formulations Containing the Compound MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD"), a clinical stage pharmaceutical company committed to developing novel therapies